Lana completes stake acquisition in Dawam International

Logo of Lana Medical Co.

Lana Medical Co. finalized the acquisition of a 21% stake in Dawam International Industrial Co., a Riyadh-based manufacturer of medical and health nutritional supplements.

The deal is valued at no more than 5% of the company’s total revenue for 2024, according to a Tadawul statement. 

The transaction will be funded through Lana’s internal resources.

The acquisition supports the company’s strategic objective to establish strong local, regional, and global partnerships and reinforce its position, sustain its leadership, and expand its market share.

For more news and details on M&As

Lana said that the establishment of Dawam International’s factory is a strategic move towards achieving self-sufficiency in the Kingdom’s medical and health supplements sector.

The factory also serves as a platform to stimulate investment in the broader medical and health industries, aligning with Saudi Arabia’s efforts to enhance quality of life and boost national exports.

Lana expects the factory to emerge as a leading Saudi brand, offering integrated nutritional solutions that meet global standards using natural, safe ingredients tailored to various consumer segments.

The facility is expected to strengthen food and health security in the Kingdom, provide high-quality local alternatives, and support export growth in this expanding sector both regionally and globally.

The company noted that all acquisition procedures, including ownership transfer and regulatory formalities, were completed on July 19. The financial impact is expected to be reflected from Jan. 1, 2026.

No related parties were involved in the deal, the statement added.

According to Argaam data, Lana generated revenues of SAR 84.09 million in 2024, with the 5% representing SAR 4.2 million.